Viral infections: Their elusive role in regulating susceptibility to autoimmune disease

Microbes and Infection

Volumn 5, Issue 10, 2003, Pages 911-921

  Flodström Tullberg, Malin ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autoimmunity; Tolerance; Virus

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON;

AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; B LYMPHOCYTE; CELL COMPARTMENTALIZATION; CYTOMEGALOVIRUS INFECTION; DISEASE PREDISPOSITION; DRUG EFFECT; EPSTEIN BARR VIRUS; HEPATITIS A; HEPATITIS C; HERPES; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; IMMUNE RESPONSE; IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MOLECULAR BIOLOGY; MULTIPLE SCLEROSIS; MUMPS; MYASTHENIA GRAVIS; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RETROVIRUS INFECTION; REVIEW; ROTAVIRUS; RUBELLA; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

EID: 0042564519     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(03)00161-8     Document Type: Review

References (158)

1. Davidson A., Diamond B. Autoimmune diseases. New Engl. J. M. 345:2001;340-350.
2. Gardner-Thorpe C., Foster J.B. Monozygous twins discordant for multiple sclerosis. Report of one pair and discussion of possible causes of multiple sclerosis. J. Neurol. Sci. 26:1975;361-375.
3. Williams A., Eldridge R., McFarland H., Houff S., Krebs H., McFarlin D. Multiple sclerosis in twins. Neurology. 30:1980;1139-1147.
4. Kumar D., Gemayel N.S., Deapen D., Kapadia D., Yamashita P.H., Lee M., Dwyer J.H., Roy-Burman P., Bray G.A., Mack T.M. North-American twins with IDDM. Genetic, etiological, and clinical significance of disease concordance according to age, zygosity, and the interval after diagnosis in first twin. Diabetes. 42:1993;1351-1363.
5. Kyvik K.O., Green A., Beck-Nielsen H. Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. Br. Med. J. 311:1995;913-917.
6. Vento S., Guella L., Mirandola F., Cainelli F., Di Perri G., Solbiati M., Ferraro T., Concia E. Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals. Lancet. 346:1995;608-609.
7. Rahaman S.M., Chira P., Koff R.S. Idiopathic autoimmune chronic hepatitis triggered by hepatitis A. Am. J. Gastroenterol. 89:1994;106-108.
8. Huppertz H.I., Treichel U., Gassel A.M., Jeschke R., Meyer zum Buschenfelde K.H. Autoimmune hepatitis following hepatitis A virus infection. J. Hepatol. 23:1995;204-208.
9. Shaw C.M., Alvord E.C. Jr. Multiple sclerosis beginning in infancy. J. Child Neurol. 2:1987;252-256.
10. Munch M., Hvas J., Christensen T., Moller-Larsen A., Haahr S. A single subtype of Epstein-Barr virus in members of multiple sclerosis clusters. Acta Neurol. Scand. 98:1998;395-399.
11. Vahlne A., Edstrom S., Hanner P., Andersen O., Svennerholm B., Lycke E. Possible association of herpes simplex virus infection with demyelinating disease. Scand. J. Infect. Dis. Suppl. 47:1985;16-21.
12. Soldan S.S., Berti R., Salem N., Secchiero P., Flamand L., Calabresi P.A., Brennan M.B., Maloni H.W., McFarland H.F., Lin H.C., Patnaik M., Jacobson S. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat. M. 3:1997;1394-1397.
13. McStreet G.H., Elkunk R.B., Latiwonk Q.I. Investigations of environmental conditions during cluster indicate probable vectors of unknown exogenous agent(s) of multiple sclerosis. Comp. Immunol. Microbiol. Infect. Dis. 15:1992;75-77.
14. Eddy S., Wim R., Peter V.E., Tanja R., Jan T., Werner V.S. Myasthenia gravis: another autoimmune disease associated with hepatitis C virus infection. Dig. Dis. Sci. 44:1999;186-189.
15. Phillips P.E., Hirshaut Y. Epstein-Barr virus antibody levels in systemic lupus erythematosus. Arthritis Rheum. 16:1973;97-101.
16. Gamble D.R., Taylor K.W. Seasonal incidence of diabetes mellitus. Br. Med. J. 3:1969;631-633.
17. Ward K.P., Galloway W.H., Auchterlonie I.A. Congenital cytomegalovirus infection and diabetes. Lancet. 1:1979;497.
18. Jenson A.B., Rosenberg H.S., Notkins A.L. Pancreatic islet-cell damage in children with fatal viral infections. Lancet. 2:1980;354-358.
19. Conrad B., Weissmahr R.N., Boni J., Arcari R., Schupbach J., Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell. 90:1997;303-313.
20. Kahana D., Berant M. Diabetes in an infant following inapparent mumps. Clin. Pediatr. (Phila). 6:1967;124-125.
21. Messaritakis J., Karabula C., Kattamis C., Matsaniotis N. Diabetes following mumps in sibs. Arch. Dis. Child. 46:1971;561-562.
22. Honeyman M.C., Coulson B.S., Stone N.L., Gellert S.A., Goldwater P.N., Steele C.E., Couper J.J., Tait B.D., Colman P.G., Harrison L.C. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes. 49:2000;1319-1324.
23. Johnson G.M., Tudor R.B. Diabetes mellitus and congenital rubella infection. Am. J. Dis. Child. 120:1970;453-455.
24. Forrest J.M., Menser M.A., Burgess J.A. High frequency of diabetes mellitus in young adults with congenital rubella. Lancet. 2:1971;332-334.
25. Plotkin S.A., Kaye R., Forrest J.M., Menser M.A., Harley J.D. Diabetes mellitus and congenital rubella. Pediatrics. 46:1970;650-651.
26. Kawai C. Idiopathic cardiomyopathy. A study on the infectious-immune theory as a cause of the disease. Jpn. Circ. J. 35:1971;765-770.
27. Olsen E.G. The pathogenesis of dilated cardiomyopathy. Postgrad. Med. J. 68:1992;S7-S10.
28. Sibley W.A., Bamford C.R., Clark K. Clinical viral infections and multiple sclerosis. Lancet. 1:1985;1313-1315.
29. Andersen O., Lygner P.E., Bergstrom T., Andersson M., Vahlne A. Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study. J. Neurol. 240:1993;417-422.
30. Stauffer Y., Marguerat S., Meylan F., Ucla C., Sutkowski N., Huber B., Pelet T., Conrad B. Interferon-alpha-induced endogenous superantigen. A model linking environment and autoimmunity. Immunity. 15:2001;591-601.
31. Gangappa S., Babu J.S., Thomas J., Daheshia M., Rouse B.T. Virus-induced immunoinflammatory lesions in the absence of viral antigen recognition. J. Immunol. 161:1998;4289-4300.
32. Zhao Z.S., Granucci F., Yeh L., Schaffer P.A., Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science. 279:1998;1344-1347.
33. Deshpande S., Zheng M., Lee S., Banerjee K., Gangappa S., Kumaraguru U., Rouse B.T. Bystander activation involving T lymphocytes in herpetic stromal keratitis. J. Immunol. 167:2001;2902-2910.
34. Huster K.M., Panoutsakopoulou V., Prince K., Sanchirico M.E., Cantor H. T cell-dependent and -independent pathways to tissue destruction following herpes simplex virus-1 infection. Eur. J. Immunol. 32:2002;1414-1419.
35. Klenerman P., Zinkernagel R.M. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature. 394:1998;482-485.
36. Haanen J.B., Wolkers M.C., Kruisbeek A.M., Schumacher T.N. Selective expansion of cross-reactive CD8(+) memory T cells by viral variants. J. Exp. M. 190:1999;1319-1328.
37. Walzl G., Tafuro S., Moss P., Openshaw P.J., Hussell T. Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology. J. Exp. M. 192:2000;1317-1326.
38. Chen H.D., Fraire A.E., Joris I., Brehm M.A., Welsh R.M., Selin L.K. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung. Nat. Immunol. 2:2001;1067-1076.
39. Culley F.J., Pollott J., Openshaw P.J. Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J. Exp. M. 196:2002;1381-1386.
40. Flodstrom M., Maday A., Balakrishna D., Cleary M.M., Yoshimura A., Sarvetnick N. Target cell defense prevents the development of diabetes after viral infection. Nat. Immunol. 3:2002;373-382.
41. Oldstone M.B. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science. 239:1988;500-502.
42. Dyrberg T., Schwimmbeck P., Oldstone M. The incidence of diabetes in BB rats is decreased following acute LCMV infection. Adv. Exp. Med. Biol. 246:1988;397-402.
43. Dyrberg T., Schwimmbeck P.L., Oldstone M.B. Inhibition of diabetes in BB rats by virus infection. J. Clin. Invest. 81:1988;928-931.
44. Wilberz S., Partke H.J., Dagnaes-Hansen F., Herberg L. Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia. 34:1991;2-5.
45. Takei I., Asaba Y., Kasatani T., Maruyama T., Watanabe K., Yanagawa T., Saruta T., Ishii T. Suppression of development of diabetes in NOD mice by lactate dehydrogenase virus infection. J. Autoimmun. 5:1992;665-673.
46. Numazaki K., Goldman H., Wong I., Wainberg M.A. Infection of cultured human fetal pancreatic islet cells by rubella virus. Am. J. Clin. Pathol. 91:1989;446-451.
47. Challoner P.B., Smith K.T., Parker J.D., MacLeod D.L., Coulter S.N., Rose T.M., Schultz E.R., Bennett J.L., Garber R.L., Chang M., et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc. Natl. Acad. Sci. USA. 92:1995;7440-7444.
48. Oldstone M.B., Southern P., Rodriquez M., Lampert P. Virus persists in beta cells of islets of Langerhans and is associated with chemical manifestations of diabetes. Science. 224:1984;1440-1443.
49. Guidotti L.G., Chisari F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19:2001;65-91.
50. Shi F., Ljunggren H.G., Sarvetnick N. Innate immunity and autoimmunity: from self-protection to self-destruction. Trends Immunol. 22:2001;97-101.
51. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14:2001;778-809. (table of contents).
52. Biron C.A. Interferons alpha and beta as immune regulators - a new look. Immunity. 14:2001;661-664.
53. Katze M.G., He Y., Gale M. Jr. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2:2002;675-687.
54. Chehadeh W., Kerr-Conte J., Pattou F., Alm G., Lefebvre J., Wattre P., Hober D. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells. J. Virol. 74:2000;10153-10164.
55. Hyoty H. Enterovirus infections and type 1 diabetes. Ann. 1000. 34:2002;138-147.
56. Akerblom H.K., Vaarala O., Hyoty H., Ilonen J., Knip M. Environmental factors in the etiology of type 1 diabetes. Am. J. Med. Genet. 115:2002;18-29.
57. Foulis A.K., Farquharson M.A., Meager A. Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet. 2:1987;1423-1427.
58. Somoza N., Vargas F., Roura-Mir C., Vives-Pi M., Fernandez-Figueras M.T., Ariza A., Gomis R., Bragado R., Marti M., Jaraquemada D., et al. Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J. Immunol. 153:1994;1360-1377.
59. Huang X., Yuang J., Goddard A., Foulis A., James R.F., Lernmark A., Pujol-Borrell R., Rabinovitch A., Somoza N., Stewart T.A. Interferon expression in the pancreases of patients with type I diabetes. Diabetes. 44:1995;658-664.
60. Rhodes C.J., Taylor K.W. Effect of human lymphoblastoid interferon on insulin synthesis and secretion in isolated human pancreatic islets. Diabetologia. 27:1984;601-603.
61. Rhodes C.J., Taylor K.W. Effect of interferon and double-stranded RNA on B-cell function in mouse islets of Langerhans. Biochem. J. 228:1985;87-94.
62. Shimizu F., Shimizu M., Kamiyama K. Inhibitory effect of interferon on the production of insulin. Endocrinology. 117:1985;2081-2084.
63. Stewart T.A., Hultgren B., Huang X., Pitts-Meek S., Hully J., MacLachlan N.J. Induction of type I diabetes by interferon-alpha in transgenic mice. Science. 260:1993;1942-1946.
64. Pelegrin M., Devedjian J.C., Costa C., Visa J., Solanes G., Pujol A., Asins G., Valera A., Bosch F. Evidence from transgenic mice that interferon-beta may be involved in the onset of diabetes mellitus. J. Biol. Chem. 273:1998;12332-12340.
65. Conrad B., Weidmann E., Trucco G., Rudert W.A., Behboo R., Ricordi C., Rodriquez-Rilo H., Finegold D., Trucco M. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature. 371:1994;351-355.
66. Pullen L.C., Miller S.D., Dal Canto M.C., Van der Meide P.H., Kim B.S. Alteration in the level of interferon-gamma results in acceleration of Theiler's virus-induced demyelinating disease. J. Neuroimmunol. 55:1994;143-152.
67. Rodriguez M., Pavelko K., Coffman R.L. Gamma interferon is critical for resistance to Theiler's virus-induced demyelination. J. Virol. 69:1995;7286-7290.
68. Fiette L., Aubert C., Muller U., Huang S., Aguet M., Brahic M., Bureau J.F. Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors. J. Exp. M. 181:1995;2069-2076.
69. Mofredj A., Howaizi M., Grasset D., Licht H., Loison S., Devergie B., Demontis R., Cadranel J.F. Diabetes mellitus during interferon therapy for chronic viral hepatitis. Dig. Dis. Sci. 47:2002;1649-1654.
70. Wilson L.E., Widman D., Dikman S.H., Gorevic P.D. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. Semin. Arthritis Rheum. 32:2002;163-173.
71. O'Connor P. Key issues in the diagnosis and treatment of multiple sclerosis. Neurology. 59:2002;S1-S33.
72. Cull V.S., Tilbrook P.A., Bartlett E.J., Brekalo N.L., James C.M. Type I interferon differential therapy for erythroleukemia: specificity of STAT activation. Blood. 21:2002;21.
73. Bartlett E.J., Cull V.S., Brekalo N.L., Lenzo J.C., James C.M. Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection. Immunol. Cell Biol. 80:2002;425-435.
74. Harle P., Cull V., Guo L., Papin J., Lawson C., Carr D.J. Transient transfection of mouse fibroblasts with type I interferon transgenes provides various degrees of protection against herpes simplex virus infection. Antiviral Res. 56:2002;39-49.
75. Harle P., Cull V., Agbaga M.P., Silverman R., Williams B.R., James C., Carr D.J. Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication. J. Virol. 76:2002;6558-6567.
76. Schlaak J.F., Hilkens C.M., Costa-Pereira A.P., Strobl B., Aberger F., Frischauf A.M., Kerr I.M. Cell-type and donor-specific transcriptional responses to interferon-alpha. Use of customized gene arrays. J. Biol. Chem. 277:2002;49428-49437.
77. Hardy M.P., Owczarek C.M., Trajanovska S., Liu X., Kola I., Hertzog P.J. The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties. Blood. 97:2001;473-482.
78. Hardy M.P., Hertzog P.J., Owczarek C.M. Multiple regions within the promoter of the murine Ifnar-2 gene confer basal and inducible expression. Biochem. J. 365:2002;355-367.
79. Grandvaux N., tenOever B.R., Servant M.J., Hiscott J. The interferon antiviral response: from viral invasion to evasion. Curr. Opin. Infect. Dis. 15:2002;259-267.
80. Mandrup-Poulsen T., Bendtzen K., Nielsen J.H., Bendixen G., Nerup J. Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy. 40:1985;424-429.
81. Southern C., Schulster D., Green I.C. Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett. 276:1990;42-44.
82. Baek H.S., Yoon J.W. Role of macrophages in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J. Virol. 64:1990;5708-5715.
83. Baek H.S., Yoon J.W. Direct involvement of macrophages in destruction of beta-cells leading to development of diabetes in virus-infected mice. Diabetes. 40:1991;1586-1597.
84. Hirasawa K., Jun H.S., Maeda K., Kawaguchi Y., Itagaki S., Mikami T., Baek H.S., Doi K., Yoon J.W. Possible role of macrophage-derived soluble mediators in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J. Virol. 71:1997;4024-4031.
85. Salazar-Mather T.P., Orange J.S., Biron C.A. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J. Exp. M. 187:1998;1-14.
86. Flodström M., Shi F.D., Sarvetnick N., Ljunggren H.G. The natural killer cell - friend or foe in autoimmune disease? Scand. J. Immunol. 55:2002;432-441.
87. French A.R., Yokoyama W.M. Natural killer cells and viral infections. Curr. Opin. Immunol. 15:2003;45-51.
88. Orange J.S., Fassett M.S., Koopman L.A., Boyson J.E., Strominger J.L. Viral evasion of natural killer cells. Nat. Immunol. 3:2002;1006-1012.
89. Moretta L., Biassoni R., Bottino C., Mingari M.C., Moretta A. Natural killer cells: a mystery no more. Scand. J. Immunol. 55:2002;229-232.
90. Borrego F., Ulbrecht M., Weiss E.H., Coligan J.E., Brooks A.G. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. M. 187:1998;813-818.
91. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285:1999;727-729.
92. Ramsey C., Winqvist O., Puhakka L., Halonen M., Moro A., Kampe O., Eskelin P., Pelto-Huikko M., Peltonen L. Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum. Mol. Genet. 11:2002;397-409.
93. Anderson M.S., Venanzi E.S., Klein L., Chen Z., Berzins S.P., Turley S.J., von Boehmer H., Bronson R., Dierich A., Benoist C., Mathis D. Projection of an immunological self shadow within the thymus by the aire protein. Science. 298:2002;1395-1401.
94. Sandberg J.K., Franksson L., Sundback J., Michaelsson J., Petersson M., Achour A., Wallin R.P., Sherman N.E., Bergman T., Jornvall H., Hunt D.F., Kiessling R., Karre K. T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity. J. Immunol. 165:2000;25-33.
95. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today. 19:1998;395-404.
96. Walker L.S., Abbas A.K. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2:2002;11-19.
97. Dhodapkar M.V., Steinman R.M. Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood. 100:2002;174-177.
98. Steinman R.M., Nussenzweig M.C. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA. 99:2002;351-358.
99. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J.V., Steinman R.M., Nussenzweig M.C. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. M. 194:2001;769-779.
100. Kurts C., Cannarile M., Klebba I., Brocker T. Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo. J. Immunol. 166:2001;1439-1442.
101. Belz G.T., Behrens G.M., Smith C.M., Miller J.F., Jones C., Lejon K., Fathman C.G., Mueller S.N., Shortman K., Carbone F.R., Heath W.R. The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. M. 196:2002;1099-1104.
102. Vogel A., Strassburg C.P., Obermayer-Straub P., Brabant G., Manns M.P. The genetic background of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and its autoimmune disease components. J. Mol. M. 80:2002;201-211.
103. Elenkov I.J., Chrousos G.P. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann. New York Acad. Sci. 966:2002;290-303.
104. Sandberg J.K., Fast N.M., Palacios E.H., Fennelly G., Dobroszycki J., Palumbo P., Wiznia A., Grant R.M., Bhardwaj N., Rosenberg M.G., Nixon D.F. Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection. J. Virol. 76:2002;7528-7534.
105. van der Vliet H.J., von Blomberg B.M., Hazenberg M.D., Nishi N., Otto S.A., van Benthem B.H., Prins M., Claessen F.A., van den Eertwegh A.J., Giaccone G., Miedema F., Scheper R.J., Pinedo H.M. Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection. J. Immunol. 168:2002;1490-1495.
106. Taniguchi M., Harada M., Kojo S., Nakayama T., Wakao H. The regulatory role of V{alpha}14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 16:2003;16.
107. Hammond K.J., Godfrey D.I. NKT cells: potential targets for autoimmune disease therapy? Tissue Antigens. 59:2002;353-363.
108. Currie P.F., Goldman J.H., Caforio A.L., Jacob A.J., Baig M.K., Brettle R.P., Haven A.J., Boon N.A., McKenna W.J. Cardiac autoimmunity in HIV related heart muscle disease. Heart. 79:1998;599-604.
109. Jahn G., Stenglein S., Riegler S., Einsele H., Sinzger C. Human cytomegalovirus infection of immature dendritic cells and macrophages. Intervirology. 42:1999;365-372.
110. Andrews D.M., Andoniou C.E., Granucci F., Ricciardi-Castagnoli P., Degli-Esposti M.A. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat. Immunol. 2:2001;1077-1084.
111. Raftery M.J., Schwab M., Eibert S.M., Samstag Y., Walczak H., Schonrich G. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity. 15:2001;997-1009.
112. Fujinami R.S., Oldstone M.B. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science. 230:1985;1043-1045.
113. Ohashi P.S., Oehen S., Buerki K., Pircher H., Ohashi C.T., Odermatt B., Malissen B., Zinkernagel R.M., Hengartner H. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 65:1991;305-317.
114. Oldstone M.B., Nerenberg M., Southern P., Price J., Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell. 65:1991;319-331.
115. Olson J.K., Croxford J.L., Calenoff M.A., Dal Canto M.C., Miller S.D. A virus-induced molecular mimicry model of multiple sclerosis. J. Clin. Invest. 108:2001;311-318.
116. Horwitz M.S., Bradley L.M., Harbertson J., Krahl T., Lee J., Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. M. 4:1998;781-785.
117. Pihlgren M., Dubois P.M., Tomkowiak M., Sjogren T., Marvel J. Resting memory CD8+ T cells are hyperreactive to antigenic challenge in vitro. J. Exp. M. 184:1996;2141-2151.
118. Curtsinger J.M., Lins D.C., Mescher M.F. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen. J. Immunol. 160:1998;3236-3243.
119. Veiga-Fernandes H., Walter U., Bourgeois C., McLean A., Rocha B. Response of naive and memory CD8+ T cells to antigen stimulation in vivo. Nat. Immunol. 1:2000;47-53.
120. Marten N.W., Stohlman S.A., Bergmann C.C. MHV infection of the CNS: mechanisms of immune-mediated control. Viral Immunol. 14:2001;1-18.
121. Dorries R. The role of T-cell-mediated mechanisms in virus infections of the nervous system. Curr. Top. Microbiol. Immunol. 253:2001;219-245.
122. Bowen D.G., Warren A., Davis T., Hoffmann M.W., McCaughan G.W., De St Groth B.F., Bertolino P. Cytokine-dependent bystander hepatitis due to intrahepatic murine CD8 T-cell activation by bone marrow-derived cells. Gastroenterology. 123:2002;1252-1264.
123. Haring J.S., Pewe L.L., Perlman S. Bystander CD8 T cell-mediated demyelination after viral infection of the central nervous system. J. Immunol. 169:2002;1550-1555.
124. Olson J.K., Girvin A.M., Miller S.D. Direct activation of innate and antigen-presenting functions of microglia following infection with Theiler's virus. J. Virol. 75:2001;9780-9789.
125. Tompkins S.M., Fuller K.G., Miller S.D. Theiler's virus-mediated autoimmunity: local presentation of CNS antigens and epitope spreading. Ann. New York Acad. Sci. 958:2002;26-38.
126. Schiffenbauer J. Superantigens and their role in autoimmune disorders. Arch. Immunol. Ther. Exp. (Warsz). 47:1999;17-24.
127. Luppi P., Zanone M.M., Hyoty H., Rudert W.A., Haluszczak C., Alexander A.M., Bertera S., Becker D., Trucco M. Restricted TCR V beta gene expression and enterovirus infection in type I diabetes: a pilot study. Diabetologia. 43:2000;1484-1497.
128. Luppi P., Licata A., Haluszczak C., Rudert W.A., Trucco G., McGowan F.X. Jr., Finegold D., Boyle G.J., Trucco M. Analysis of TCR Vbeta repertoire and cytokine gene expression in patients with idiopathic dilated cardiomyopathy. J. Autoimmun. 16:2001;3-13.
129. Soos J.M., Schiffenbauer J., Johnson H.M. Treatment of PL/J mice with the superantigen, staphylococcal enterotoxin B, prevents development of experimental allergic encephalomyelitis. J. Neuroimmunol. 43:1993;39-43.
130. Selin L.K., Varga S.M., Wong I.C., Welsh R.M. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J. Exp. M. 188:1998;1705-1715.
131. Schlesinger C., Meyer C.A., Veeraraghavan S., Koss M.N. Constrictive (obliterative) bronchiolitis: diagnosis, etiology, and a critical review of the literature. Ann. 500iagn. Pathol. 2:1998;321-334.
132. Yang H.Y., Joris I., Majno G., Welsh R.M. Necrosis of adipose tissue induced by sequential infections with unrelated viruses. Am. J. Pathol. 120:1985;173-177.
133. Evans C.F., Horwitz M.S., Hobbs M.V., Oldstone M.B. Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease. J. Exp. M. 184:1996;2371-2384.
134. Kuchroo V.K., Anderson A.C., Waldner H., Munder M., Bettelli E., Nicholson L.B. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20:2002;101-123.
135. Ruiz P.J., Garren H., Hirschberg D.L., Langer-Gould A.M., Levite M., Karpuj M.V., Southwood S., Sette A., Conlon P., Steinman L. Microbial epitopes act as altered peptide ligands to prevent experimental autoimmune encephalomyelitis. J. Exp. M. 189:1999;1275-1284.
136. Munder M., Bettelli E., Monney L., Slavik J.M., Nicholson L.B., Kuchroo V.K. Reduced self-reactivity of an autoreactive T cell after activation with cross-reactive non-self-ligand. J. Exp. M. 196:2002;1151-1162.
137. Anderton S.M., Radu C.G., Lowrey P.A., Ward E.S., Wraith D.C. Negative selection during the peripheral immune response to antigen. J. Exp. M. 193:2001;1-11.
138. Naniche D. Generalized immunosuppression: individual viruses, intertwined targets. Virology. 275:2000;227-232.
139. Knox K.K., Pietryga D., Harrington D.J., Franciosi R., Carrigan D.R. Progressive immunodeficiency and fatal pneumonitis associated with human herpesvirus 6 infection in an infant. Clin. Infect. Dis. 20:1995;406-413.
140. Wang F.Z., Linde A., Dahl H., Ljungman P. Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation. Bone Marrow Transplant. 24:1999;1201-1206.
141. Cloyd M.W., Chen J.J., Adeqboyega P., Wang L. How does HIV cause depletion of CD4 lymphocytes? A mechanism involving virus signaling through its cellular receptors. Curr. Mol. M. 1:2001;545-550.
142. Salmi A.A. Suppression of T-cell immunity after measles infection: is the puzzle solved? Trends Microbiol. 5:1997;85-86.
143. Ge Q., Hu H., Eisen H.N., Chen J. Different contributions of thymopoiesis and homeostasis-driven proliferation to the reconstitution of naive and memory T cell compartments. Proc. Natl. Acad. Sci. USA. 99:2002;2989-2994.
144. Theofilopoulos A.N., Dummer W., Kono D.H. T cell homeostasis and systemic autoimmunity. J. Clin. Invest. 108:2001;335-340.
145. Ramanathan S., Bihoreau M.T., Paterson A.D., Marandi L., Gauguier D., Poussier P. Thymectomy and radiation-induced type 1 diabetes in nonlymphopenic BB rats. Diabetes. 51:2002;2975-2981.
146. Goldrath A.W. Maintaining the status quo: T-cell homeostasis. Microbes Infect. 4:2002;539-545.
147. Ge Q., Rao V.P., Cho B.K., Eisen H.N., Chen J. Dependence of lymphopenia-induced T cell proliferation on the abundance of peptide/MHC epitopes and strength of their interaction with T cell receptors. Proc. Natl. Acad. Sci. USA. 98:2001;1728-1733.
148. Gleeson P.A., Toh B.H., van Driel I.R. Organ-specific autoimmunity induced by lymphopenia. Immunol. Rev. 149:1996;97-125.
149. Sherer Y., Shoenfeld Y. Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant. 22:1998;873-881.
150. Graves P.M., Norris J.M., Pallansch M.A., Gerling I.C., Rewers M. The role of enteroviral infections in the development of IDDM: limitations of current approaches. Diabetes. 46:1997;161-168.
151. Roivainen M., Ylipaasto P., Savolainen C., Galama J., Hovi T., Otonkoski T. Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia. 45:2002;693-702.
152. Kastrukoff L.F., Lau A.S., Puterman M.L. Genetics of natural resistance to herpes simplex virus type 1 latent infection of the peripheral nervous system in mice. J. Gen. Virol. 67:1986;613-621.
153. Thomas E.E., Lau A.S., Kim S.U., Osborne D., Kastrukoff L.F. Variation in resistance to herpes simplex virus type 1 of oligodendrocytes derived from inbred strains of mice. J. Gen. Virol. 72:1991;2051-2057.
154. Kastrukoff L.F., Kim S.U. Oligodendrocytes from human donors differ in resistance to herpes simplex virus 1 (HSV-1). Glia. 38:2002;87-92.
155. Cardozo A.K., Kruhoffer M., Leeman R., Orntoft T., Eizirik D.L. Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays. Diabetes. 50:2001;909-920.
156. Cardozo A.K., Heimberg H., Heremans Y., Leeman R., Kutlu B., Kruhoffer M., Orntoft T., Eizirik D.L. A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. J. Biol. Chem. 276:2001;48879-48886.
157. Frigerio S., Junt T., Lu B., Gerard C., Zumsteg U., Hollander G.A., Piali L. Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat. M. 8:2002;1414-1420.
158. Cooney R.N. Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway. Shock. 17:2002;83-90.